Stemina Biomarker Discovery Inc. today announced the launch of the largest clinical study of the metabolism of children with autism spectrum disorder (ASD) ever conducted. The Children’s Autism Metabolome Project or “CAMP” study will enroll 1,500 subjects from six sites across the country. CAMP will attempt to confirm that sets of metabolic biomarkers can detect subtypes of ASD.
NeuroPointDX Presented Poster at IMFAR 2017: Metabolic Profiling of the Children’s Autism Metabolome Project (CAMP)
Metabolic Profiling of the Children’s Autism Metabolome Project (CAMP) NeuroPointDX is conducting a research study called Children’s Autism